Detection of Variants With Reduced Baloxavir Marboxil Susceptibility After Treatment of Children With Influenza A During the 2018-2019 Influenza Season

被引：25

作者：

Sato, Masatoki ^{[1
]}

Takashita, Emi ^{[2
]}

Katayose, Masahiko ^{[3
]}

Nemoto, Kenji ^{[4
]}

Sakai, Nobuko ^{[5
]}

Hashimoto, Koichi ^{[1
]}

Hosoya, Mitsuaki ^{[1
]}

机构：

[1] Fukushima Med Univ, Dept Pediat, 1 Hikarigaoka, Fukushima 9601295, Japan

[2] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo, Japan

[3] Nanohana Kids Clin, Soma, Japan

[4] Nemoto Kids Clin, Shirakawa, Japan

[5] Jin Kids Clin, Koriyama, Fukushima, Japan

来源：

JOURNAL OF INFECTIOUS DISEASES | 2020年 / 222卷 / 01期

基金：

日本学术振兴会;

关键词：

antiviraltherapy; baloxavir; influenza; oseltamivir; resistance; ADULTS;

D O I：

10.1093/infdis/jiaa061

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

During the 2018-2019 influenza seasons, we detected reduced baloxavir marboxil (baloxavir) susceptible variants with I38S or I38T amino acid substitutions on the PA subunit of influenza virus ribonucleic acid polymerase in 7 of 18 baloxavi-treated children and found that virus titer rebounded in some of these children with variants. We also found fever durations to be similar between patients with or without the variants, but the patients with variants shed the virus 3 days longer and took longer to improve clinical symptoms than those without variants. The emergence of these variants should be monitored during future influenza seasons.

引用

页码：121 / 125

页数：5

共 50 条

[41] Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018-2019 United States Influenza Season
Boikos, Constantina
Imran, Mahrukh
Van Hung Nguyen
Ducruet, Thierry
Sylvester, Gregg C.
Mansi, James A.
OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (07):
[42] Evaluating impact of school outreach vaccination programme in Hong Kong influenza season 2018-2019
Lau, Yu Lung
Wong, Wilfred Hing Sang
Hattangdi-Haridas, Sonal R.
Chow, Chun Bong
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (04) : 823 - 826
[43] ETIOLOGY OF INFLUENZA-LIKE ILLNESSES IN THE POPULATION OF NOVOSIBIRSK CITY IN THE 2018-2019 EPIDEMIC SEASON
Kurskaya, O. G.
Anoshina, A., V
Leonova, N., V
Simkina, O. A.
Komissarova, T., V
Esikova, E. Yu
Pozdnyakova, L. L.
Sobolev, I. A.
Prokopyeva, E. A.
Kazachkova, E. A.
Danilenko, D. M.
Komissarov, A. B.
Stolyarov, K. A.
Fadeev, A., V
Sominina, A. A.
Sharshov, K. A.
Yu, Alekseev A.
Shestopalov, A. M.
Murashkina, T. A.
INFEKTSIYA I IMMUNITET, 2021, 11 (04): : 723 - 736
[44] Efficacy of baloxavir marboxil as a prophylactic against influenza among in-patients and analysis of influenza virus mutations in their isolates at a Japanese hospital during the 2023–2024 flu season
Akihide Fujii
Tomohiro Oishi
Eisei Kondo
Zyunko Morihara
Yuka Ikeda
Hideyuki Sumida
Youko Ninomiya
Satoe Uesugi
Kimie Okazaki
Daisuke Yoshioka
Miyoko Kobayashi
Hideho Wada
Journal of Pharmaceutical Health Care and Sciences, 11 (1)
[45] Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory droplets
Masaki Imai
Makoto Yamashita
Yuko Sakai-Tagawa
Kiyoko Iwatsuki-Horimoto
Maki Kiso
Jurika Murakami
Atsuhiro Yasuhara
Kosuke Takada
Mutsumi Ito
Noriko Nakajima
Kenta Takahashi
Tiago J. S. Lopes
Jayeeta Dutta
Zenab Khan
Divya Kriti
Harm van Bakel
Akifumi Tokita
Haruhisa Hagiwara
Naomi Izumida
Haruo Kuroki
Tamon Nishino
Noriyuki Wada
Michiko Koga
Eisuke Adachi
Daisuke Jubishi
Hideki Hasegawa
Yoshihiro Kawaoka
Nature Microbiology, 2020, 5 : 27 - 33
[46] Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory droplets
Imai, Masaki
Yamashita, Makoto
Sakai-Tagawa, Yuko
Iwatsuki-Horimoto, Kiyoko
Kiso, Maki
Murakami, Jurika
Yasuhara, Atsuhiro
Takada, Kosuke
Ito, Mutsumi
Nakajima, Noriko
Takahashi, Kenta
Lopes, Tiago J. S.
Dutta, Jayeeta
Khan, Zenab
Kriti, Divya
van Bakel, Harm
Tokita, Akifumi
Hagiwara, Haruhisa
Izumida, Naomi
Kuroki, Haruo
Nishino, Tamon
Wada, Noriyuki
Koga, Michiko
Adachi, Eisuke
Jubishi, Daisuke
Hasegawa, Hideki
Kawaoka, Yoshihiro
NATURE MICROBIOLOGY, 2020, 5 (01) : 27 - +
[47] Guillain-Barre Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018-2019 Season
Perez-Vilar, Silvia
Hu, Mao
Weintraub, Eric
Arya, Deepa
Lufkin, Bradley
Myers, Tanya
Woo, Emily Jane
Lo, An-Chi
Chu, Steve
Swarr, Madeline
Liao, Jiemin
Wernecke, Michael
MaCurdy, Tom
Kelman, Jeffrey
Anderson, Steven
Duffy, Jonathan
Forshee, Richard A.
JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (03): : 416 - 425
[48] Adult influenza A (H3N2) with reduced susceptibility to baloxavir or peramivir cured after switching anti-influenza agents
Seki, Masafumi
Sakai-Tagawa, Yuko
Yasuhara, Atsuhiro
Watanabe, Yuji
IDCASES, 2019, 18
[49] Predominance of a Drifted Influenza A (H3N2) Clade and Its Association with Age-Specific Influenza Vaccine Effectiveness Variations, Influenza Season 2018-2019
Glatman-Freedman, Aharona
Pando, Rakefet
Sefty, Hanna
Omer, Itay
Rosenberg, Alina
Drori, Yaron
Nemet, Ital
Mendelson, Ella
Keinan-Boker, Lital
Mandelboim, Michal
VACCINES, 2020, 8 (01)
[50] A cost-effectiveness analysis of reduced viral transmission with baloxavir marboxil versus oseltamivir or no treatment for seasonal and pandemic influenza management in the United Kingdom
Kommandantvold, Svenn Alexander
Lemenuel-Diot, Annabelle
Skedgel, Chris
Pitman, Richard
Rouse, Peter
Zaraket, Hassan
Zhou, Hao
Zumofen, Marie-Helene Blanchet
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2024, 24 (08) : 953 - 966

← 1 2 3 4 5 →